Get the Stockscreener App
163.93
0.52%
0.85
After Hours:
163.93
Davita Inc stock is traded at $163.93, with a volume of 470.91K.
It is up +0.52% in the last 24 hours and up +8.62% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
See More
Previous Close:
$163.08
Open:
$164.31
24h Volume:
470.91K
Relative Volume:
0.68
Market Cap:
$14.38B
Revenue:
$12.52B
Net Income/Loss:
$859.62M
P/E Ratio:
32.59
EPS:
5.03
Net Cash Flow:
$1.27B
1W Performance:
+1.45%
1M Performance:
+8.62%
6M Performance:
+18.75%
1Y Performance:
+73.42%
1-Day Range:
$161.99
$164.31
1-Week Range:
$159.27
$165.78
52-Week Range:
$71.51
$166.04
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Is DaVita Inc.'s (NYSE:DVA) ROE Of 47% Impressive? - Yahoo Finance
Those who invested in DaVita (NYSE:DVA) five years ago are up 193% - Simply Wall St
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Acquires 3,794 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Inc. (NYSE:DVA) Shares Sold by APG Asset Management N.V. - MarketBeat
DaVita Inc. (NYSE:DVA) Shares Purchased by Maverick Capital Ltd. - MarketBeat
DaVita Reaches $34 Million False Claims Act Settlement - Policy & Medicine
Wall Street SWOT: DaVita stock navigates dialysis market shifts amid policy changes - Investing.com
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors - Yahoo Finance
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying? - MSN
Is DaVita Stock Outperforming the Dow? - Nasdaq
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is DaVita Stock Outperforming the Dow? - MSN
DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying? - Yahoo Finance
Is DaVita Stock Outperforming The Dow? - Barchart
Ensign Peak Advisors Inc Lowers Stock Position in DaVita Inc. (NYSE:DVA) - MarketBeat
Ensign Peak Advisors Inc Reduces Stock Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Inc. (DVA): Warren Buffett’s Best Stock Performer of 2024 - Yahoo Finance
Ariel Investments LLC Sells 256,666 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita HealthCare (DVA) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term - Yahoo Finance
XTX Topco Ltd Purchases Shares of 4,746 DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Inc. (NYSE:DVA) Shares Sold by Skandinaviska Enskilda Banken AB publ - MarketBeat
Intech Investment Management LLC Has $4.13 Million Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
Promethos Capital LLC Raises Stake in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DaVita (NYSE:DVA) Hits New 52-Week High at $166.04 - MarketBeat
Up 50% This Year, DaVita (DVA) Continues To Capture Interest - AskTraders
DaVita Inc. (NYSE:DVA) Stake Lifted by Meiji Yasuda Asset Management Co Ltd. - MarketBeat
DVA (DaVita) Enterprise Value : $25,017 Mil (As of Sep. 18, 2024) - GuruFocus.com
Ex-Davita Employee Alleges Harassment Over Time Off for IVF Process - MyNewsLA.com
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market - Yahoo Finance
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
These Are the 5 Most Heavily Shorted Stocks on the NYSE - Investopedia
20,146 Shares in DaVita Inc. (NYSE:DVA) Purchased by Seven Eight Capital LP - MarketBeat
DaVita Inc. (DVA): Best Long-Term Stock to Buy According To Warren Buffett - Insider Monkey
DaVita Inc. (DVA): Best Long-Term Stock to Buy According To Warren Buffett - Yahoo Finance
Javier J. Rodriguez - Gilead Sciences
DaVita Inc (DVA) CEO Javier Rodriguez Sells 59,881 Shares - GuruFocus.com
DaVita Inc. (NYSE:DVA) CEO Sells $1,609,120.85 in Stock - MarketBeat
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
DaVita Accelerates Commitment to Community Health with Nationwide Tour - PR Newswire
An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued - Simply Wall St
Harvard Management Co. Inc. Invests $55.12 Million in DaVita Inc. (NYSE:DVA) - MarketBeat
Zacks Investment Ideas feature highlights: Intuitive Surgical, SharkNinja and DaVita - Yahoo Finance
Forsta AP Fonden Purchases 10,500 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
Goldman Thinks DaVita Inc. (DVA) Is A Long-Term AI Stock Set To Rally Eventually - Insider Monkey
Goldman Thinks DaVita Inc. (DVA) Is A Long-Term AI Stock Set To Rally Eventually - Yahoo Finance
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):